IL1B and COVID-19: Individuals with COVID-19 have been reported to have high levels of major inflammatory cytokines such as IL-6, IL-1β, and TNF-α in the circulation (Yang et al., 2020a; Yang et al., 2020b), which was associated with the magnitude of disease severity (Wu et al., 2020).